Invitae (NYSE:NVTA) Receives New Coverage from Analysts at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA) in a note issued to investors on Tuesday. The firm set a “hold” rating on the medical research company’s stock.

Invitae Price Performance

Shares of NYSE NVTA opened at $0.00 on Tuesday. The company has a market cap of $400,515.00, a PE ratio of 0.00 and a beta of 1.59. Invitae has a 12 month low of $0.02 and a 12 month high of $0.02. The company has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.36.

Institutional Investors Weigh In On Invitae

A number of hedge funds and other institutional investors have recently modified their holdings of NVTA. SG Americas Securities LLC purchased a new stake in Invitae in the third quarter valued at approximately $29,000. Janney Montgomery Scott LLC lifted its position in Invitae by 404.6% during the third quarter. Janney Montgomery Scott LLC now owns 63,105 shares of the medical research company’s stock valued at $38,000 after buying an additional 50,600 shares in the last quarter. Financial Gravity Asset Management Inc. lifted its position in Invitae by 1,799.5% during the third quarter. Financial Gravity Asset Management Inc. now owns 73,929 shares of the medical research company’s stock valued at $45,000 after buying an additional 70,037 shares in the last quarter. Pathstone Family Office LLC lifted its position in Invitae by 94.2% during the third quarter. Pathstone Family Office LLC now owns 157,972 shares of the medical research company’s stock valued at $96,000 after buying an additional 76,639 shares in the last quarter. Finally, Harbor Capital Advisors Inc. lifted its position in Invitae by 24.1% during the third quarter. Harbor Capital Advisors Inc. now owns 224,642 shares of the medical research company’s stock valued at $136,000 after buying an additional 43,642 shares in the last quarter. 61.28% of the stock is currently owned by hedge funds and other institutional investors.

About Invitae

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services.